Evidence map›Paper›PMID 34234266›Full record

ArticleJournal of human genetics2022

The return of individual genomic results to research participants: design and pilot study of Tohoku Medical Megabank Project.

Hiroshi Kawame, Akimune Fukushima, Nobuo Fuse, Fuji Nagami, Yoichi Suzuki, Mika Sakurai-Yageta, Jun Yasuda, Yumi Yamaguchi-Kabata, Kengo Kinoshita, Soichi Ogishima and 22 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 2 institutions in 1 country.

Hiroshi KawameTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan. hkawame@megabank.tohoku.ac.jp.
Akimune FukushimaIwate Tohoku Medical Megabank Organization, Iwate Medical University, Iwate, Japan.
Nobuo FuseTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.ORCID http://orcid.org/0000-0003-0237-4746
Fuji NagamiTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.
Yoichi SuzukiTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.ORCID http://orcid.org/0000-0002-3843-5080
Mika Sakurai-YagetaTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.
Jun YasudaTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.
Yumi Yamaguchi-KabataTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.
Kengo KinoshitaTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.ORCID http://orcid.org/0000-0003-3453-2171
Soichi OgishimaTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.
Takako TakaiTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.
Shinichi KuriyamaTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.ORCID http://orcid.org/0000-0002-6445-0911
Atsushi HozawaTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.
Naoki NakayaTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.
Tomohiro NakamuraTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.
Naoko MinegishiTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.
Junichi SugawaraTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.
Kichiya SuzukiTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.
Hiroaki TomitaTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.ORCID http://orcid.org/0000-0003-2628-880X
Akira UrunoTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.
Tomoko KobayashiTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.
Yayoi AizawaTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.ORCID http://orcid.org/0000-0002-4415-8307
Tomoharu TokutomiIwate Tohoku Medical Megabank Organization, Iwate Medical University, Iwate, Japan.ORCID http://orcid.org/0000-0003-3001-9936
Kayono YamamotoDepartment of Clinical Genetics, Iwate Medical University, Iwate, Japan.
Kinuko OhnedaTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan. kohneda@megabank.tohoku.ac.jp.
Shigeo KureTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.
Yoko AokiDepartment of Medical Genetics, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Hideki KatagiriDepartment of Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Yasushi IshigakiIwate Tohoku Medical Megabank Organization, Iwate Medical University, Iwate, Japan.
Shojiro SawadaDepartment of Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Makoto SasakiIwate Tohoku Medical Megabank Organization, Iwate Medical University, Iwate, Japan.
Masayuki YamamotoTohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan. masiyamamoto@med.tohoku.ac.jp.ORCID http://orcid.org/0000-0002-9073-9436
Tohoku University · JPIwate Medical University · JP

Funding

Ministry of Education, Culture, Sports, Science and Technology (MEXT) JP 19km0105001Ministry of Education, Culture, Sports, Science and Technology (MEXT) JP 19km0105002Ministry of Education, Culture, Sports, Science and Technology (MEXT) JP 19km0105003Ministry of Education, Culture, Sports, Science and Technology (MEXT) JP 19km0105004
6 · The paper itself

Abstract

Certain large genome cohort studies attempt to return the individual genomic results to the participants; however, the implementation process and psychosocial impacts remain largely unknown. The Tohoku Medical Megabank Project has conducted large genome cohort studies of general residents. To implement the disclosure of individual genomic results, we extracted the potential challenges and obstacles. Major challenges include the determination of genes/disorders based on the current medical system in Japan, the storage of results, prevention of misunderstanding, and collaboration of medical professionals. To overcome these challenges, we plan to conduct multilayer pilot studies, which deal with different disorders/genes. We finally chose familial hypercholesterolemia (FH) as a target disease for the first pilot study. Of the 665 eligible candidates, 33.5% were interested in the pilot study and provided consent after an educational "genetics workshop" on the basic genetics and medical facts of FH. The genetics professionals disclosed the results to the participants. All positive participants were referred to medical care, and a serial questionnaire revealed no significant psychosocial distress after the disclosure. Return of genomic results to research participants was implemented using a well-prepared protocol. To further elucidate the impact of different disorders, we will perform multilayer pilot studies with different disorders, including actionable pharmacogenomics and hereditary tumor syndromes.

Indexed as

Genetics, MedicalGenomeGenomicsResearchDatabases, GeneticDisclosureHumansJapanPharmacogeneticsPilot ProjectsResearch Design

Identifiers

PMID34234266
OpenAlexW3182418697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.